2026年11月4日星期三
M
Wereldwijde Kroniek
Wereldwijd nieuws
Apple's new CEO delivers first earnings as sales hit record— 日经 Nikkei AsiaJapan's Aisin develops new type of AI chip that cuts energy use 98%— 日经 Nikkei AsiaEthics drive Wardah to pinnacle of Southeast Asia's beauty brands— 日经 Nikkei AsiaCyber insurance inquiries surge at Japan's nonlife insurers— 日经 Nikkei AsiaSingapore's Insignia Ventures backs rural Japan for Davos-inspired academy— 日经 Nikkei AsiaThe great yen rebalancing— 日经 Nikkei AsiaNintendo's Mario creator Miyamoto sees 'things we can do' even in AI era— 日经 Nikkei AsiaNorth Korea leans on China and Russia to drive 3% economic growth— 日经 Nikkei AsiaApple's new CEO delivers first earnings as sales hit record— 日经 Nikkei AsiaJapan's Aisin develops new type of AI chip that cuts energy use 98%— 日经 Nikkei AsiaEthics drive Wardah to pinnacle of Southeast Asia's beauty brands— 日经 Nikkei AsiaCyber insurance inquiries surge at Japan's nonlife insurers— 日经 Nikkei AsiaSingapore's Insignia Ventures backs rural Japan for Davos-inspired academy— 日经 Nikkei AsiaThe great yen rebalancing— 日经 Nikkei AsiaNintendo's Mario creator Miyamoto sees 'things we can do' even in AI era— 日经 Nikkei AsiaNorth Korea leans on China and Russia to drive 3% economic growth— 日经 Nikkei Asia

Povorcitinib for nonsegmental vitiligo: two randomized, controlled, phase 3 STOP-V trials

Bron Nature 医学研究1 dagen geleden
Samenvatting van de inhoud

Deze site biedt alleen een index van titels en samenvattingen. De volledige inhoud en het auteursrecht behoren toe aan de oorspronkelijke uitgever. Klik op de originele link om te lezen.

Ga naar het origineel
Behorend kanaal
Gezondheid
Behorende regio
Wereldwijd perspectief
Taal van het origineel
English
Itemnummer
health-00a74bed

Comments 0 comments

No comments yet. Be the first.

Povorcitinib for nonsegmental vitiligo: two randomized, controlled, phase 3 STOP-V trials · Wereldwijde Kroniek